Insider buying
~$96K5,514 sh @ $17.38
Traded Oct 2, 2024 · filed 2 days later
A Cartesian Therapeutics director paid $96K out of pocket for Cartesian Therapeutics shares. It was the first purchase in over a year.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 3, 2024 · Filed Oct 4, 2024
A Cartesian Therapeutics director paid $176K out of pocket for Cartesian Therapeutics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$175,840
Shares × reported transaction price
$100K–$500K
+0.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 1 earlier confirmed purchase
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
56 days after results of Aug 8, 2024, 35 days before results of Nov 7, 2024
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.5% | +0.9% | −2.4% |
| 30 days | −6.6% | +3.6% | −10.2% |
| 90 days | −22.8% | +2.0% | −24.8% |
| 180 days | −54.5% | −12.6% | −41.9% |
| 365 days | −54.5% | +16.3% | −70.8% |
Past results only. Not a forecast.
Insider buying
Traded Oct 2, 2024 · filed 2 days later
A Cartesian Therapeutics director paid $96K out of pocket for Cartesian Therapeutics shares. It was the first purchase in over a year.
Insider buying
Traded Oct 3, 2024 · filed 1 day later
A Cartesian Therapeutics director paid $545K out of pocket for Cartesian Therapeutics shares.
Insider buying
Traded Oct 3, 2024 · filed 1 day later
A Cartesian Therapeutics director paid $195K out of pocket for Cartesian Therapeutics shares.
Timothy A Springer, Director's past purchases, 90 days after disclosure: 10 buys, median −12.3 pts vs S&P 500, beat it 4 of 10 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.